Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Świtaj · SciRah

Researcher profile · Semantic Scholar

T. Świtaj

Share profile

T. Świtaj — researcher profile on SciRah

h-index: 21
Works: 119
Citations: 1,592

Most-cited papers

Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
P. Rutkowski, E. Bylina, A. Wozniak, Z. Nowecki +9 more
2011European Journal of Surgical Oncology172 citations
Semantic Scholar
Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas.
H. Koseła-Paterczyk, Milena Szacht, T. Morysiński, I. Ługowska +7 more
2014European Journal of Surgical Oncology100 citations
Semantic Scholar
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
P. Rutkowski, E. Bylina, A. Klimczak, T. Świtaj +13 more
2012BMC Cancer75 citations Open access
Semantic Scholar
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
P. Schöffski, M. Kubíčková, A. Wozniak, J. Blay +14 more
2021European Journal of Cancer67 citations Open access
Semantic Scholar
Advances in Molecular Characterization and Targeted Therapy in Dermatofibrosarcoma Protuberans
P. Rutkowski, A. Wozniak, T. Świtaj
2011Sarcoma47 citations Open access
Semantic Scholar
Long-term Results of Therapy with Sunitinib in Metastatic Alveolar Soft Part Sarcoma
P. Jagodzińska-Mucha, T. Świtaj, K. Kozak, H. Koseła-Paterczyk +6 more
2017Tumori41 citations
Semantic Scholar
Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
H. Koseła-Paterczyk, P. Teterycz, M. Spałek, A. Borkowska +10 more
2021Cancers39 citations Open access
Semantic Scholar
Diagnosis and treatment of malignant PEComa tumours
Aleksandra Sobiborowicz, A. Czarnecka, A. Szumera-Ciećkiewicz, P. Rutkowski +1 more
202032 citations Open access
Semantic Scholar
Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
P. Sobczuk, P. Teterycz, A. Czarnecka, T. Świtaj +4 more
2020Journal of Clinical Medicine29 citations Open access
Semantic Scholar
Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions
A. Czarnecka, J. Skoczylas, E. Bartnik, T. Świtaj +1 more
2023Cancer Management and Research26 citations Open access
Semantic Scholar
Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
Aleksandra Sobiborowicz, T. Świtaj, P. Teterycz, M. Spałek +5 more
2021Journal of Clinical Medicine26 citations Open access
Semantic Scholar
Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective
T. Świtaj, Aleksandra Sobiborowicz, P. Teterycz, A. Klimczak +5 more
2021Journal of Clinical Medicine25 citations Open access
Semantic Scholar
GUIDELINES FOR DIAGNOSTIC AND THERAPEUTIC MANAGEMENT
Piotr Rutkowski, P. Wysocki, A. Nasierowska-Guttmejer, A. Jeziorski +16 more
201725 citations
Semantic Scholar
What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
P. Rutkowski, J. Andrzejuk, E. Bylina, C. Osuch +8 more
2013Medical Oncology24 citations Open access
Semantic Scholar
Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice
A. Czarnecka, P. Teterycz, A. Mariuk-Jarema, I. Lugowska +4 more
2019Targeted oncology21 citations
Semantic Scholar
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
J. Przybyl, K. Kozak, H. Koseła, S. Falkowski +10 more
2014Medical Oncology21 citations Open access
Semantic Scholar
Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients
S. Markowicz, Z. Nowecki, P. Rutkowski, A. Lipkowski +7 more
2012Medical Oncology21 citations
Semantic Scholar
Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
P. Sobczuk, P. Teterycz, A. Czarnecka, T. Świtaj +7 more
2020Surgical oncology20 citations
Semantic Scholar
Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
K. Wiater, T. Świtaj, J. Mackiewicz, E. Kalinka-Warzocha +6 more
2013Contemporary oncology20 citations Open access
Semantic Scholar
Czerniaki skóry — zasady postępowania diagnostyczno-terapeutycznego w 2013 roku
P. Rutkowski, P. Wysocki, Zbigniew I. Nowecki, L. Rudnicka +12 more
201220 citations
Semantic Scholar
What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference center.
P. Sobczuk, I. Agnieszczak, W. Grycuk, A. Czarnecka +5 more
2021European Journal of Surgical Oncology19 citations
Semantic Scholar
Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis
K. Kozak, A. Kowalik, A. Gos, B. Wasąg +12 more
2020Tumori19 citations
Semantic Scholar
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
B. Cybulska-Stopa, I. Ługowska, P. Jagodzińska-Mucha, H. Koseła-Paterczyk +11 more
2019Advances in Dermatology and Allergology19 citations Open access
Semantic Scholar
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)
P. Rutkowski, B. Jagielska, J. Andrzejuk, E. Bylina +6 more
2017Contemporary oncology18 citations Open access
Semantic Scholar
Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience
P. Jagodzińska-Mucha, A. Raciborska, H. Koseła-Paterczyk, K. Kozak +6 more
2021Journal of Clinical Medicine16 citations Open access
Semantic Scholar
Expert recommendations on diagnostic-therapeutic management of melanoma patients
P. Rutkowski, P. Wysocki, K. Kozak, A. Nasierowska-Guttmejer +24 more
2022Oncology in Clinical Practice14 citations Open access
Semantic Scholar
Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma
A. Czarnecka, K. Ostaszewski, A. Borkowska, A. Szumera-Ciećkiewicz +10 more
2021Cancers14 citations Open access
Semantic Scholar
Skin carcinomas
P. Rutkowski, W. Owczarek, D. Nejc, A. Jeziorski +10 more
2020Oncology in Clinical Practice14 citations Open access
Semantic Scholar
The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice.
P. Rutkowski, M. Ziętek, B. Cybulska-Stopa, J. Streb +11 more
2020European Journal of Surgical Oncology14 citations Open access
Semantic Scholar
OC-0069 5x5 Gy with chemotherapy in borderline resectable soft tissue sarcomas: early results of a trial
M. Spałek, H. Koseła-Paterczyk, A. Borkowska, M. Wągrodzki +8 more
2019Radiotherapy and Oncology14 citations Open access
Semantic Scholar
Management of brain metastases in melanoma
P. Rutkowski, D. Kiprian, M. Dudzisz-Śledź, T. Świtaj +4 more
201914 citations
Semantic Scholar
Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
M. Słowińska, M. Dudzisz-Śledź, P. Sobczuk, I. Łasińska +12 more
2022Journal of the European Academy of Dermatology and Venereology13 citations Open access
Semantic Scholar
High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors
P. Teterycz, P. Jagodzińska-Mucha, B. Cybulska-Stopa, A. Mariuk-Jarema +14 more
2018Melanoma research13 citations
Semantic Scholar
Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.
P. Rutkowski, J. Przybyl, T. Świtaj
2014International Journal of Biochemistry and Cell Biology13 citations
Semantic Scholar
Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
B. Cybulska-Stopa, M. Skoczek, M. Ziobro, T. Świtaj +5 more
2013Contemporary oncology13 citations Open access
Semantic Scholar
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
J. Placzke, M. Rosińska, P. Sobczuk, M. Ziętek +19 more
2023Cancers12 citations Open access
Semantic Scholar
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence
A. Czarnecka, P. Sobczuk, P. Rogala, T. Świtaj +8 more
2022Cancer Immunology and Immunotherapy12 citations Open access
Semantic Scholar
The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
P. Sobczuk, K. Kozak, S. Kopeć, P. Rogala +5 more
2022Cancers11 citations Open access
Semantic Scholar
The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma
P. Jagodzińska-Mucha, I. Ługowska, T. Świtaj, H. Koseła-Paterczyk +7 more
2020International Journal of Clinical Oncology10 citations
Semantic Scholar
The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma
K. Kozak, P. Teterycz, T. Świtaj, H. Koseła-Paterczyk +7 more
2020Journal of Clinical Medicine9 citations Open access
Semantic Scholar
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence
P. Rogala, A. Czarnecka, B. Cybulska-Stopa, K. Ostaszewski +16 more
2022Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Management of melanoma metastases in the brain
P. Rutkowski, D. Kiprian, M. Dudzisz-Śledź, T. Świtaj +4 more
2019Nowotwory Journal of Oncology8 citations Open access
Semantic Scholar
Expert recommendation on diagnostic-therapeutic management in skin carcinomas
P. Rutkowski, W. Owczarek, D. Nejc, A. Jeziorski +16 more
2022Oncology in Clinical Practice7 citations Open access
Semantic Scholar
Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
M. Dudzisz-Śledź, P. Sobczuk, K. Kozak, T. Świtaj +15 more
2022Cancers6 citations Open access
Semantic Scholar
Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors.
Anna Szumera-Cieækiewicz, Olga Kuczkiewicz-Siemion, K. Seliga, Magdalena Grabowska-Kierył +5 more
2019Polish journal of pathology : official journal of the Polish Society of Pathologists6 citations Open access
Semantic Scholar
The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
P. Rutkowski, K. Kozak, J. Mackiewicz, K. Krzemieniecki +6 more
2015Contemporary oncology6 citations Open access
Semantic Scholar
[Antitumor effects of sulindac in ovarian cell cultures].
A. Jakubowska-Mućka, J. Sieńko, T. Świtaj, J. Gołąb +1 more
2011Ginekologia Polska6 citations
Semantic Scholar
Diagnosis and treatment of rhabdomyosarcomas
M. Łomiak, T. Świtaj, M. Spałek, Joanna Radzikowska +7 more
2023Oncology in Clinical Practice4 citations Open access
Semantic Scholar
Diagnosis and treatment of angiomyolipoma (AML) tumours
Aleksandra Sobiborowicz, A. Czarnecka, A. Szumera-Ciećkiewicz, P. Rutkowski +1 more
20204 citations
Semantic Scholar
Cutaneous melanoma – guidelines for diagnostics and therapy in 2016
P. Rutkowski, P. Wysocki, A. Nasierowska-Guttmejer, J. Fijuth +9 more
20164 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Rutkowski×45
Invite
P. Rutkowski — researcher profile on SciRah
H. Koseła-Paterczyk×25
Invite
H. Koseła-Paterczyk — researcher profile on SciRah
K. Kozak×21
Invite
K. Kozak — researcher profile on SciRah
A. Czarnecka×19
Invite
A. Czarnecka — researcher profile on SciRah

×16

Invite

S. Falkowski — researcher profile on SciRah

A. Szumera-Ciećkiewicz×13

Invite

A. Szumera-Ciećkiewicz — researcher profile on SciRah

P. Teterycz×11

Invite

P. Teterycz — researcher profile on SciRah

I. Ługowska×9

Invite

I. Ługowska — researcher profile on SciRah

M. Zdzienicki×9

Invite

M. Zdzienicki — researcher profile on SciRah

Invite

A. Klimczak — researcher profile on SciRah

Invite

P. Rogala — researcher profile on SciRah

M. Wągrodzki×9

Invite

M. Wągrodzki — researcher profile on SciRah